Riboflavin: Clinical Trials

27 trials of Riboflavin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 unknown, 10 completed, 3 withdrawn, 2 terminated. 27 Phase 2, 7 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 227Unknown 11, Completed 10, Withdrawn 3, Terminated 2, Recruiting 1
Phase 37Unknown 4, Completed 1, Recruiting 1, Withdrawn 1
Phase 15Completed 2, Unknown 2, Terminated 1

Follow Riboflavin: new trials by email Literature Review of Riboflavin trials Research Report on Riboflavin

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia
Riboflavin 0.1% ophthalmic solution and pulsed light, Riboflavin 0.1% ophthalmic solution and non-pulsed light - Keratoconus, Corneal Ectasia
Phase 2 / Phase 3RecruitingPrice Vision Group5002025-10-012026-09-25
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer
Phase 2 / Phase 3UnknownPeschke GmbH4882022-03-142022-10-28
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care Therapy + Sham CXL + Artificial Tears - Keratitis, Corneal Ulcer
Phase 2 / Phase 3UnknownPeschke GmbH4682022-03-142022-10-28
Riboflavin for Glutamate Reduction in Alcohol Withdrawal
Riboflavin, Placebo - Alcohol Withdrawal, Nutrition Disorders
Phase 2UnknownOregon Health and Science University402021-12-012021-09-29
Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position
PXL 330 Platinum device/Riboflavin - Keratoconus, Unstable, Ectasia Corneal
Phase 2CompletedEye Specialists of Indiana122020-05-042024-08-29
Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure
Oral Riboflavin - Axial Myopia, Refractive Errors
Phase 2WithdrawnUniversity of Missouri-Columbia2018-10-102026-08-24
A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis
ISIS 416858, Placebo - End-stage Renal Disease (ESRD)
Phase 2CompletedIonis Pharmaceuticals, Inc.2132017-12-262023-01-20
Ramelteon in the Prevention of Post-operative Delirium
Ramelteon, Microcrystalline Cellulose, Riboflavin 100 mg - Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders
Phase 2CompletedJohns Hopkins University802017-03-242020-06-30
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Riboflavin, Dextran, UVA Light Source - Keratolysis
Phase 1 / Phase 2CompletedJoseph B. Ciolino, MD762017-03-152023-05-10
Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota
Riboflavin Dose 1, Riboflavin Dose 2, Placebo - Gut Microbiota
Phase 2Completeddsm-firmenich Switzerland AG1052016-11-012020-01-22
The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Riboflavin, Placebo - Psoriasis
Phase 2CompletedUniversity of Michigan232016-08-112022-07-28
The Impact of Riboflavin on Sports-related Concussion
Riboflavin, Placebo - Sports-related Concussion
Phase 2UnknownUniversity of Virginia5002016-08-012017-08-11
Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain
acetazolamide, Quinine, Riboflavin - Compliance, Chronic Pain
Phase 2WithdrawnGeorgetown University2014-12-012017-02-10
Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus
adjusted corneal collagen cross-linking, accelerated corneal collagen cross-linking, riboflavin 0.1% combined with dextran 20 % - Keratoconus
Phase 1 / Phase 2UnknownTehran University of Medical Sciences402014-08-012015-07-23
Treatment of Keratoconus With Advanced CXL-II
Topography-based CXL (KXL2), Conventional pulsed CXL (pCXL), Riboflavin - Keratoconus
Phase 2UnknownUmeå University502014-03-012018-05-16
The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)
Methotrexate, Riboflavin - Myocardial Infarction
Phase 2UnknownInstituto de Cardiologia do Rio Grande do Sul802013-04-012013-04-09
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Theralight crosslinking and Riboflavin - Keratoconus
Phase 2TerminatedCxlusa13242013-01-012018-10-12
Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).
UV-X 1000 (3 mW/cm²), UV-X 2000 (9 mW/cm²), riboflavin with hydroxypropyl methylcellulose - Keratoconus, Corneal Ectasia
Phase 1 / Phase 2UnknownOslo University Hospital402012-08-012016-08-30
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Riboflavin - Chemical Injuries, Unspecified Complication of Corneal Transplant
Phase 1 / Phase 2CompletedJoseph B. Ciolino, MD12012-03-012019-10-21
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
UV-X Light, Riboflavin - Keratoconus, Ectasia
Phase 2UnknownMercy Center for Corrective Eye Surgery2502011-03-012011-03-29

Showing 20 of 27. Sign in to see all of them.

Conditions studied

Keratoconus (11)  ·  Dilatation, Pathologic (4)  ·  Corneal Diseases (2)  ·  Corneal Ulcer (2)  ·  Keratitis (2)  ·  Acidosis, Lactic (1)  ·  Alcoholism (1)  ·  Arthritis, Rheumatoid (1)  ·  Autoimmune Diseases (1)  ·  Brain Concussion (1)  ·  Chronic Pain (1)  ·  Cognitive Dysfunction (1)  ·  Delayed Emergence from Anesthesia (1)  ·  Delirium (1)  ·  Emergence Delirium (1)

Sponsors

Joseph B. Ciolino, MD (2)  ·  Peschke GmbH (2)  ·  Price Vision Group (2)  ·  Cxlusa (1)  ·  Eye Specialists of Indiana (1)  ·  Georgetown University (1)  ·  Instituto de Cardiologia do Rio Grande do Sul (1)  ·  Ionis Pharmaceuticals, Inc. (1)  ·  Johns Hopkins University (1)  ·  Mercy Center for Corrective Eye Surgery (1)  ·  New York State Psychiatric Institute (1)  ·  Ohio State University (1)  ·  Oregon Health and Science University (1)  ·  Oslo University Hospital (1)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)

Countries

United States (17)  ·  Brazil (1)  ·  Canada (1)  ·  Iran (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Bala Ambati (2)  ·  Yvette Viscuso (2)  ·  Aleksandar Stojanovic, MD (1)  ·  Brandon Cornejo, MD, PhD (1)  ·  Carlos AM Gottschall, MD MSc PhD (1)  ·  Daniel M. Moreira, MD. MSc (1)  ·  Daniel M. Moreira, MD. MSc. (1)  ·  Ezra Maguen, M.D. (1)  ·  Fateme Alipour, MD (1)  ·  Francis Price, MD (1)  ·  Francis W Price, MD (1)  ·  Hermie J.M. Harmsen, PhD (1)  ·  Hilary J Powers, PhD (1)  ·  James Salz, M.D. (1)  ·  Johann Gudjonsson, MD (1)

Results publications

PMID 16765803, PMID 16952090, PMID 18471635, PMID 18811118, PMID 20138607, PMID 20164744, PMID 22741619, PMID 27899371, PMID 28325070, PMID 29203068, PMID 32532654, PMID 32557558, PMID 35943883

NIH funding

2017 (1), P50DA009236 (1), R21AG050850 (1)